IND SWIFT LABORATORIES LT vs SUN PHARMACEUTICAL IND L
A side-by-side comparison of IND SWIFT LABORATORIES LT (INDSWFTLAB) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, SUN PHARMACEUTICAL IND L leads INDSWFTLAB vs SUNPHARMA on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability04
- Growth02
- Size & financial health13
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
SUNPHARMA takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
SUNPHARMA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
SUNPHARMA takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
SUNPHARMA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has reduced debt.", "Company is almost debt free.", "Company is expected to give good quarter"]
- − ["Though the company is reporting repeated profits, it is not paying out dividend", "The company has delivered a poor sales growth of -6.37% over past five years.", "Company has a low return on equity of 6.11% over last 3 years.", "Earnings include an other income of Rs.44.1 Cr.", "Debtor days have increased from 89.4 to 113 days.", "Working capital days have increased from 94.1 days to 165 days"]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.